Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages
Pharmacoepidemiology and Drug Safety · 2026-06 · 35 (6)
DOI: 10.1002/pds.70393 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 19.05.2026. Verfasst von Katie J Suda und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Healthcare Evaluation, Research, and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Veterans, Drug Monitoring, Prescription Drugs. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HSRD VA, U.S. Department of Veterans Affairs.
Abstract (Originalsprache)
Introduction
Although drug shortages for outpatient chronic conditions commonly occur, population‐level data on how they impact patients' ability to refill prescriptions is scarce. We sought to identify distinct patterns of refill adherence following drug shortages and patient‐ and prescription‐level factors associated with adherence trajectories reflecting potential shortage‐related treatment disruption.
Methods
We retrospectively analyzed panel data assembled from 2017 to 2020 Veterans Health Administration (VHA) electronic health record data. Patients were included if they were baseline users of medications subject to a shortage within VHA. Group‐based trajectory modeling was applied to users' monthly proportion of days covered (PDC) values from 6‐months before to 6‐months after the reported drug supply chain disruption. Patient demographics and medication characteristics were compared between identified trajectory groups using multivariable logistic regression.
Results
Among 1.5 million episodes of medication use (representing 1.3 million unique Veterans) for 29 medications in shortage in VHA, 6.3% were for female patients and the mean age was 66.4 ± 12.8 years. A 4‐group trajectory model had the best fit: High Adherence (69.2% of observations), Moderate Adherence (14.1%), Potential Shortage‐Related Disruption (8.5%), and Pre‐Shortage Disruption (8.3%). Drug characteristics (drug class, number of manufacturers) were more strongly associated than patient characteristics with having Potential Shortage‐Related Treatment Disruption vs. High Adherence.
Conclusions
We identified 4 trajectories of refill adherence for medications subject to VHA drug shortages, with 8.5% of users of affected drugs exhibiting a trajectory consistent with shortage‐related treatment disruption. Drug characteristics may modify whether drug shortages lead to treatment disruption in VHA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Healthcare Evaluation, Research, and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.
- Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- VA Center for Medication Safety/Pharmacy Benefits Management Services, Hines, Illinois, USA.
- School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Pediatrics, Division of General Academic Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- VA Pharmacy Benefits Management Services, Washington, DC, USA.
ORCID-Profile: Sherrie L Aspinall, Taylor L Boyer, Walid F Gellad, Chester B Good, Mina Tadrous
Förderung
- HSRD VA
- U.S. Department of Veterans Affairs
Zitieren
APA
Suda, K. J., Zhao, X., Aspinall, S. L., Li, Y., Callaway Kim, K., Cunningham, F. E., Boyer, T. L., Miner, T. W., Kima, C., Gellad, W. F., Glassman, P. A., Good, C. B., Skelton, F., Tadrous, M., & Thorpe, C. T. (2026). Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages. Pharmacoepidemiology and Drug Safety, 35(6). https://doi.org/10.1002/pds.70393
Vancouver
Suda KJ, Zhao X, Aspinall SL, Li Y, Callaway Kim K, Cunningham FE, et al. Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages. Pharmacoepidemiology and Drug Safety. 2026;35(6). doi:10.1002/pds.70393
BibTeX
@article{Suda2026,
author = {Suda, Katie J and Zhao, Xinhua and Aspinall, Sherrie L and Li, Yaming and Callaway Kim, Katherine and Cunningham, Francesca E and Boyer, Taylor L and Miner, Tate W and Kima, Clara and Gellad, Walid F and Glassman, Peter A and Good, Chester B and Skelton, Felicia and Tadrous, Mina and Thorpe, Carolyn T},
title = {Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2026},
volume = {35},
number = {6},
doi = {10.1002/pds.70393}
}
EUVIMED